Klaus Kapelari

Datos Biográficos

ID7188684
NOMBREKlaus Kapelari
NOMBRESKlaus
APELLIDOKapelari
FIRMAKAPELARI K
AFILIACIONESInnsbruck Medical University
VERIFICADONo
TOTAL DE OBRAS3
TOTAL DE CITAS0
TOTAL COMO AUTOR3
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2013
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0

  • Acceptance and impact of Nirsevimab and the RSVpreF vaccine following implementation in Austria

    Open AccessMichaela Höck, Wegene Borena et al.ARTICLEFrontiers in Public Health2025

    Background Since summer 2024, passive immunization with nirsevimab (Beyfortus ® ) has been recommended for all infants in Austria to prevent severe respiratory syncytial virus (RSV) infection. Maternal vaccination with RSVpreF (Abrysvo ® ), which provides transplacental protection, became available in autumn 2023. The expected public health benefits of these preventive strategies depend largely on widespread acceptance; however, real-world data f…

  • Weight and body mass index (BMI)

    Open AccessMichael Mayer, Andreas Gleiss et al.ARTICLEAnnals of Human Biology2014

    Overweight and obesity are common in Austria and their prevalence is increasing (using the same IOTF reference for international comparison). Up-to-date national BMI reference values are provided to classify children and adolescents according to the proposed overweight and obesity thresholds

  • Austrian height and body proportion references for children aged 4 to under 19 years

    Open AccessAndreas Gleiss, Michael Lassi et al.ARTICLEAnnals of Human Biology2013

    After the age of 5 years national reference curves are more suitable than the WHO reference curves for clinical use in Austria. These height curves are very similar to the German reference curves published recently. Therefore, these reference curves for criteria of body proportions are recommended for use in other populations. Further validation studies are needed to establish whether the recently recommended -2.5 and -3.0 SD for height are a sen…